Pharmaceutical Products Companies By Roe
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Return On Equity
| ROE | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | TLX | Telix Pharmaceuticals Limited | (0.15) | 3.16 | (0.49) | ||
| 2 | XOMAP | XOMA Corp | 0.07 | 0.67 | 0.05 | ||
| 3 | XOMAO | XOMA Corporation | 0.15 | 0.41 | 0.06 | ||
| 4 | VCEL | Vericel Corp Ord | (0.05) | 3.33 | (0.15) | ||
| 5 | MDCX | Medicus Pharma Ltd | (0.05) | 9.24 | (0.44) | ||
| 6 | MENS | Jyong Biotech Ltd | 0.36 | 10.26 | 3.65 | ||
| 7 | 090572AR9 | BIO 33 15 MAR 27 | (0.12) | 0.64 | (0.08) | ||
| 8 | 69832AAC0 | MATSEL 3113 19 JUL 29 | (0.21) | 0.79 | (0.16) | ||
| 9 | MNKD | MannKind Corp | (0.08) | 3.01 | (0.23) | ||
| 10 | 090572AQ1 | BIO 37 15 MAR 32 | 0.03 | 1.11 | 0.03 | ||
| 11 | CEROW | CERo Therapeutics Holdings | 0.12 | 34.36 | 4.04 | ||
| 12 | NWBO | Northwest Biotherapeutics | (0.01) | 3.98 | (0.05) | ||
| 13 | MDCXW | Medicus Pharma Ltd | 0.11 | 29.00 | 3.18 | ||
| 14 | HROWM | Harrow Health, 11875 | 0.09 | 0.47 | 0.04 | ||
| 15 | IMA | ImageneBio, | 0.12 | 4.15 | 0.48 | ||
| 16 | LIMNW | Liminatus Pharma, Warrants | 0.19 | 33.94 | 6.45 | ||
| 17 | 072722AE1 | US072722AE18 | 0.13 | 1.51 | 0.20 | ||
| 18 | PTHS | Pelthos Therapeutics | 0.13 | 13.45 | 1.79 | ||
| 19 | BCTXZ | BriaCell Therapeutics Corp | (0.17) | 10.09 | (1.70) | ||
| 20 | HYPD | Hyperion DeFi, | 0.21 | 26.88 | 5.52 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income. For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.